These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 86931)

  • 1. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
    Michelot R; Leviel V; Giorguieff-Chesselet MF; Chéramy A; Glowinski J
    Life Sci; 1979 Feb; 24(8):715-23. PubMed ID: 86931
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J; Michelot R; Chéramy A
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract]   [Full Text] [Related]  

  • 3. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
    Herrera-Marschitz M; Christensson-Nylander I; Sharp T; Staines W; Reid M; Hökfelt T; Terenius L; Ungerstedt U
    Exp Brain Res; 1986; 64(1):193-207. PubMed ID: 2429859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons.
    Cheramy A; Michelot R; Leviel V; Nieoullon A; Glowinski J; Kerdelhue B
    Brain Res; 1978 Oct; 155(2):404-8. PubMed ID: 688024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade by frontocortical lesion of reciprocal regulation between the two nigrostriatal dopaminergic pathways.
    Leviel V; Kerny C; Barberis C; Guibert B; Daudet F
    Neuroscience; 1984 Sep; 13(1):53-9. PubMed ID: 6092996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity.
    Feltz P
    Appl Neurophysiol; 1979; 42(1-2):47-50. PubMed ID: 222207
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation by stress of the habenulo-interpeduncular substance P neurons in the rat.
    Lisoprawski A; Blanc G; Glowinski J
    Neurosci Lett; 1981 Aug; 25(1):47-51. PubMed ID: 6168982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 10. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
    Olianas MC; De Montis GM; Mulas G; Tagliamonte A
    Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
    [No Abstract]   [Full Text] [Related]  

  • 11. Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.
    Hanson GR; Alphs L; Wolf W; Levine R; Lovenberg W
    J Pharmacol Exp Ther; 1981 Aug; 218(2):568-74. PubMed ID: 6166743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of sensory stimuli on the activity of dopaminergic neurons: involvement of non-dopaminergic nigral neurons and striato-nigral pathways.
    Hommer DW; Bunney BS
    Life Sci; 1980 Aug; 27(5):377-86. PubMed ID: 7412480
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the dendritic release of dopamine in the reciprocal control of the two nigro-striatal dopaminergic pathways.
    Leviel V; Chéramy A; Glowinski J
    Nature; 1979 Jul; 280(5719):236-9. PubMed ID: 450141
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of substance P in the nigrostriatal system.
    Borison RL; Klawans HL; Diamond BI
    Int J Neurol; 1980; 14(2-4):189-94. PubMed ID: 6194132
    [No Abstract]   [Full Text] [Related]  

  • 16. The striatum and substantia nigra: a commentary on their relationships.
    Dray A
    Neuroscience; 1979; 4(10):1407-39. PubMed ID: 233319
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of dopamine in the striatum, with a consideration of thalamic inputs.
    McLennan H
    Appl Neurophysiol; 1979; 42(1-2):40-2. PubMed ID: 222206
    [No Abstract]   [Full Text] [Related]  

  • 18. The striatonigral substance P pathway and dopaminergic mechanisms.
    Glowinski J; Torrens Y; Beaujouan JC
    Ciba Found Symp; 1982; (91):281-95. PubMed ID: 6183075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the thalamus in the reciprocal regulation of the two nigrostriatal dopaminergic pathways.
    Chéramy A; Leviel V; Daudet F; Guibert B; Chesselet MF; Glowinski J
    Neuroscience; 1981; 6(12):2657-68. PubMed ID: 7322356
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional mechanism of the striatum by integration of nine types of synapses which have at least seven different transmitters.
    Hassler R
    Int J Neurol; 1979; 13(1-4):94-116. PubMed ID: 45452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.